CINECA IRIS Institutional Research Information System

KOPECKA, Joanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.229
AS - Asia 3.713
EU - Europa 3.464
AF - Africa 80
SA - Sud America 60
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 8
Totale 13.600
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.057
CN - Cina 2.296
IT - Italia 1.108
SG - Singapore 468
SE - Svezia 396
IE - Irlanda 356
AT - Austria 254
FR - Francia 239
DE - Germania 228
UA - Ucraina 156
JP - Giappone 153
HK - Hong Kong 142
FI - Finlandia 138
GB - Regno Unito 127
IN - India 112
PL - Polonia 107
VN - Vietnam 97
ID - Indonesia 96
KR - Corea 93
MX - Messico 91
CA - Canada 80
TW - Taiwan 78
DK - Danimarca 73
RU - Federazione Russa 49
TR - Turchia 48
AU - Australia 42
ES - Italia 40
NL - Olanda 39
BE - Belgio 38
IR - Iran 36
SN - Senegal 33
BR - Brasile 24
CH - Svizzera 21
TH - Thailandia 19
CO - Colombia 18
GR - Grecia 18
RO - Romania 18
MY - Malesia 17
EG - Egitto 14
ZA - Sudafrica 12
NO - Norvegia 11
PT - Portogallo 11
CZ - Repubblica Ceca 10
IL - Israele 10
MO - Macao, regione amministrativa speciale della Cina 9
AE - Emirati Arabi Uniti 7
AR - Argentina 7
AM - Armenia 6
BY - Bielorussia 6
EU - Europa 6
PE - Perù 6
BG - Bulgaria 5
HU - Ungheria 5
LB - Libano 5
TN - Tunisia 5
MU - Mauritius 4
NZ - Nuova Zelanda 4
PH - Filippine 4
SA - Arabia Saudita 4
SI - Slovenia 4
DZ - Algeria 3
EC - Ecuador 3
IQ - Iraq 3
NG - Nigeria 3
SK - Slovacchia (Repubblica Slovacca) 3
UZ - Uzbekistan 3
BA - Bosnia-Erzegovina 2
CL - Cile 2
JO - Giordania 2
PK - Pakistan 2
SD - Sudan 2
A1 - Anonimo 1
AP - ???statistics.table.value.countryCode.AP??? 1
AZ - Azerbaigian 1
CI - Costa d'Avorio 1
HR - Croazia 1
LU - Lussemburgo 1
MA - Marocco 1
MM - Myanmar 1
MW - Malawi 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SC - Seychelles 1
Totale 13.600
Salva come PNG Salva come JPEG
Città #
Chandler 649
Fairfield 489
Beijing 454
Houston 368
Ashburn 363
Singapore 357
Dublin 354
Torino 326
Ann Arbor 315
Woodbridge 259
Vienna 235
Wilmington 216
Seattle 186
Cambridge 175
Shanghai 171
Guangzhou 157
Turin 157
Santa Clara 156
Nyköping 144
Dearborn 135
Redwood City 125
Pisa 108
Nanjing 106
Villeurbanne 105
Columbus 103
Medford 103
Princeton 98
Jakarta 86
New York 84
Hangzhou 82
Jacksonville 70
Warsaw 67
Wuhan 67
Dong Ket 59
Fremont 59
Taipei 49
Changsha 44
Shenyang 41
Chengdu 40
Milan 40
San Diego 40
Tokyo 40
Central 39
Boston 38
Helsinki 34
Boardman 32
Hefei 31
Los Angeles 31
Chongqing 30
Tianjin 30
Toronto 30
Rome 28
Xian 27
Zhengzhou 26
Istanbul 25
Seoul 24
Jinan 23
Phoenix 23
Hebei 21
Hong Kong 21
London 21
Brussels 19
Fuzhou 19
San Mateo 19
Shenzhen 19
Buffalo 18
Mountain View 18
Central District 16
Florence 16
Norwalk 16
Changchun 15
Chennai 15
Chicago 15
Pune 15
San Giuliano Milanese 15
Upper Marlboro 15
Washington 15
Kunming 14
Paris 14
Birmingham 13
Frankfurt am Main 13
Detroit 12
Ottawa 12
Xiamen 12
Bari 11
Dallas 11
Falls Church 11
Guiyang 11
Harbin 11
Las Vegas 11
Nanchang 11
Siena 11
Silver Spring 11
Athens 10
Bologna 10
Moscow 10
Nanning 10
Piemonte 10
Qingdao 10
Xi'an 10
Totale 8.340
Salva come PNG Salva come JPEG
Nome #
Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets 1.646
Hypoxia as a driver of resistance to immunotherapy 643
Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment 468
Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3-signalling. 300
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts 294
REGULATION OF HIF-1 alpha IN TP53 DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND ITS POTENTIAL ROLE AS A THERAPEUTIC TARGET 287
Cholesterol metabolism: At the cross road between cancer cells and immune environment 283
Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5 273
Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance. 266
Potential diagnostic and prognostic role of micro-environment in malignant pleural mesothelioma 260
Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma 259
PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy 257
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors 256
The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells 248
ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma 240
An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells 225
Design and synthesis of fluorescent ligands for the detection of cannabinoid type 2 receptor (CB2R) 219
Insights in the chemical components of liposomes responsible for P-glycoprotein inhibition. 201
Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells 182
Liposomal Nitrooxy-Doxorubicin: One Step over Caelyx in Drug-Resistant Human Cancer Cells 177
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer 175
Small nucleolar RNAs determine resistance to doxorubicin in human osteosarcoma 171
Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: A combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors 168
Effects of chrysotile exposure in human bronchial epithelial cells: Insights into the pathogenic mechanisms of asbestos-related diseases 168
Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells 161
Multi-walled carbon nanotubes directly induce epithelial-mesenchymal transition in human bronchial epithelial cells via the TGF-β-mediated Akt/GSK-3β/SNAIL-1 signalling pathway 160
Curcumin-loaded solid lipid nanoparticles bypass p-glycoprotein mediated doxorubicin resistance in triple negative breast cancer cells 153
Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma 148
The cross-talk between canonical and non-canonical Wnt-dependent pathways regulates P-glycoprotein expression in human blood-brain barrier cells. 147
HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia 142
Nitric oxide and P-glycoprotein modulate the phagocytosis of colon cancer cells 136
ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer 135
Temozolomide down-regulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/GSK3/β-catenin pathway 127
Carbonic Anhydrase XII Inhibitors Overcome Temozolomide Resistance in Glioblastoma 124
Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells 123
Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance 113
A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells 111
Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies 111
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma 110
P-glycoprotein-mediated chemoresistance is reversed by carbonic anhydrase XII inhibitors 110
Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition. 109
New tetrahydroisoquinoline derivatives overcome pgp activity in brain-blood barrier and glioblastoma multiforme in vitro 108
Mitochondrial delivery of phenol substructure triggers mitochondrial depolarization and apoptosis of cancer cells 104
Endothelial Cells Promote Osteogenesis by Establishing a Functional and Metabolic Coupling With Human Mesenchymal Stem Cells 104
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma 103
Regulation of HIF-1α in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role as a Therapeutic Target 102
Zoledronic acid restores doxorubicin chemosensitivity and immunogenic cell death in multidrug-resistant human cancer cells 98
Cardiac glycosides as new modulators of cholesterol metabolism 95
Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein 94
Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death 92
Pleiotropic Effects of Cardioactive Glycosides. 91
Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons 88
IL17A Depletion Affects the Metabolism of Macrophages Treated with Gemcitabine 88
HIF-1 alpha Upregulation in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role As a Therapeutic Target 87
Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance. 84
Digoxin and ouabain induce the efflux of cholesterol via LXR signalling and the synthesis of ATP in cardiomyocytes. 82
Mechanisms of Vgamma9Vdelta2 T cell activation by soluble metabolites generated by the mevalonate pathway. 81
Cardiac glycosides modulate cholesterol metabolism via SREBP-2 and LXR activation 79
ω-3 long chain polyunsaturated fatty acids as sensitizing agents and multidrug resistance revertants in cancer therapy 77
The Hypoxia-Inducible Factor-1 alpha Is Constitutively Upregulated in TP53 Disrupted CLL Cells: A Potential Target to Overcome Fludarabine Resistance 77
Liposomal doxorubicin reverses drug-resistance by inhibiting P-glycoprotein in human cancer cells 72
Temozolomide epigenetically down-regulates Wnt3a-dependent signaling and P- glycoprotein in glioblastoma stem cells 72
Digoxin and oubain increase the synthesis of cholesterol in human liver cells 72
Regulation of HIF-1α in TP53 disrupted chronic lymphocytic leukemia cells and its potential role as a therapeutic target 72
Mitochondrial metabolism: Inducer or therapeutic target in tumor immune-resistance? 72
Targeting hif-1α regulatory pathways as a strategy to hamper tumor-microenvironment interactions in cll 72
Two repeated low doses of doxorubicin are more effective than one single high dose against tumors overexpressing P-glycoprotein 71
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma 71
Cardioactive glycosides induce the efflux of cholesterol by upregulating ABCA1 69
Mrp1-collateral sensitizers as a novel therapeutic approach in resistant cancer therapy: An in vitro and in vivo study in lung resistant tumor 69
Endothelial heme dynamics drive cancer cell metabolism by shaping the tumor microenvironment 69
iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells 67
Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein-Mediated Resistance to Temozolomide in Glioblastoma 67
REGULATION OF HIF-1 IN TP53 DISRUPTED CLL CELLS AND ITS INHIBITION AS A STRATEGY TO OVERCOME FLUDARABINE RESISTANCE 67
The Role of C/EBP-β LIP in Multidrug Resistance 63
Targeting mitochondrial oncometabolites: A new approach to overcome drug resistance in cancer 62
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity 59
The “LDL-masked doxorubicin”: an effective strategy for drug delivery across hypoxic blood brain barrier 59
Sigma-2 receptor and progesterone receptor membrane component 1 (PGRMC1) are two different proteins: Proofs by fluorescent labeling and binding of sigma-2 receptor ligands to PGRMC1 58
REGULATION OF HIF-1 alpha IN TP53 DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND ITS POTENTIAL ROLE AS A THERAPEUTIC TARGET 54
Regulation of HIF-1α in TP53 disrupted chronic lymphocytic leukemia cells and its potential role as a therapeutic target 53
Click ferrocenyl-erlotinib conjugates active against erlotinib-resistant non-small cell lung cancer cells in vitro 51
Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells. 48
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity 48
Pleiotropic effects of liposomal nanoparticles on ABCB1 in cancer cells 47
Targeting mevalonate pathway down-regulates ABCB1, reversing chemoresistance and immunoresistance in human cancer cells. 46
The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells 46
Autocrine 17-β-estradiol/estrogen receptor-α loop determines the response to immune-checkpoint inhibitors in non-small cell lung cancer 44
Structure-Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands 44
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity 43
Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status 42
Multifunctional thiosemicarbazones targeting sigma receptors: in vitro and in vivo antitumor activities in pancreatic cancer models 39
Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer 36
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity 36
Nanoparticle- and liposome-carried drugs: new strategies for active targeting and drug delivery across blood-brain barrier. 36
Electronic Coupling in 1,2,3-Triazole Bridged Ferrocenes and Its Impact on Reactive Oxygen Species Generation and Deleterious Activity in Cancer Cells 34
p140Cap modulates the mevalonate pathway decreasing cell migration and enhancing drug sensitivity in breast cancer cells 33
mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells 32
Designing functionalized nanodiamonds with hyaluronic acid–phospholipid conjugates for enhanced cancer cell targeting and fluorescence imaging capabilities 28
Malignant mesothelioma 26
Totale 13.769
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.409
article - articoli 0
book - libri 0
conference - conferenze 5.404
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.813
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.209 0 0 0 0 107 236 157 134 158 174 125 118
2020/20212.161 106 232 144 165 211 156 199 172 178 187 176 235
2021/20222.132 121 103 111 218 89 118 159 148 139 190 426 310
2022/20232.335 217 181 84 184 189 503 204 158 255 83 134 143
2023/20242.180 200 216 133 150 143 335 166 170 56 195 188 228
2024/20251.350 108 275 222 303 442 0 0 0 0 0 0 0
Totale 13.937